Starting on Remsima^® (for patients who have never received infliximab before)

Remsima^®, which contains the active ingredient infliximab, is only available on prescription.

• Before you start using Remsima^®, which is given subcutaneously (in an injection under the skin), you will be given two intravenous infusions of infliximab (in a vein, usually in your arm, over period of 2 hours) by your doctor or nurse.


• After the first two intravenous infusions, the first dose of Remsima^® subcutaneous injection will be administered under the supervision of your doctor.


• After proper training, if you feel you are well trained and confident to inject Remsima^® yourself, your doctor may allow you to inject subsequent doses of Remsima^® yourself at home.

For Rheumatoid Arthritis^1,2

Your doctor will start your treatment with two infliximab intravenous infusion doses of 3 mg for every kg of body weight (given to you into a vein, usually in your arm, over a period of 2 hours). They are administered 2 weeks apart via intravenous infusion. After 4 weeks from the last intravenous infusion, you will be given Remsima^® via injection under the skin (subcutaneous injection). The usual recommended dose of Remsima^® subcutaneous injection is 120 mg once every 2 weeks regardless of weight.

For Ankylosing Spondylitis, Psoriatic Arthritis and/or Psoriasis^1,2

Your doctor will start your treatment with two infliximab intravenous infusion doses of 5 mg for every kg of body weight (given to you into a vein, usually in your arm, over a period of 2 hours). They are administered 2 weeks apart via intravenous infusion. After 4 weeks from the last intravenous infusion, you will be given Remsima^® via injection under the skin (subcutaneous injection). The usual recommended dose of Remsima^® subcutaneous injection is 120 mg once every 2 weeks regardless of weight.

For Crohn's Disease and Ulcerative Colitis^1,2

Your doctor will start your treatment with two infliximab intravenous infusion doses of 5 mg for every kg of body weight (given to you into a vein, usually in your arm, over a period of 2 hours). They are administered 2 weeks apart via intravenous infusion. After 4 weeks from the last intravenous infusion, you will be given Remsima^® via injection under the skin (subcutaneous injection). The usual recommended dose of Remsima^® subcutaneous injection is 120 mg once every 2 weeks regardless of weight.

When Starting Remsima^® Treatment^1,2

• DAY 1 WEEK 0

  

  1st infliximab IV infusion

  
  • Your doctor will start your treatment with infliximab intravenous infusion (given to you into a vein, usually in your arm, over a period of 2 hours).

• WEEK 2

  

  2nd infliximab IV infusion

  
  • After 2 weeks, infliximab is administered again as an IV infusion into a vein by qualified healthcare professional.¹

• WEEK 6

  

  1st SC injection

  
  • After 4 weeks from the last intravenous infusion, you will be given Remsima^® via injection under the skin (subcutaneous injection).

• WEEK 8* EVERY 2 WEEKS

  

  SC injection at home

  
  • After proper training, if you feel you are well trained and confident to inject Remsima^® yourself, your doctor may allow you to inject subsequent doses of Remsima^® yourself at home.

Switching from intravenous infliximab to subcutaneous Remsima^®3

When switching from the maintenance (long-term) therapy of infliximab intravenous infusion, the subcutaneous formulation can be given 8 weeks after the last administration of the intravenous infusion of infliximab.

After proper training, if you feel you are well trained and confident to inject Remsima^® yourself, your healthcare professional may allow you to inject subsequent doses of subcutaneous Remsima^® yourself at home.

Important dosing information